<html>
<head>PUBMED IDs for OSBPL3</head>
<body bgcolor='#C5F0F2'><h1>OSBPL3</h1><a href='https://pubmed.ncbi.nlm.nih.gov/26762204/'>Identification of Patients with Recurrent Glioblastoma Who May Benefit from Combined Bevacizumab and CCNU Therapy: A Report from the BELOB Trial.</a> June 29  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/28388590/'>Integrated expression profiles analysis reveals novel predictive biomarker in pancreatic ductal adenocarcinoma.</a> April 8  2017<br></body></html>
